US Tech 100

19,868.00

0.11%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NPSP

Nps (NPSP)

(MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NPSP

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Date	Time	Source	Headline	Symbol	Company
08/01/2013	8:06AM	Business Wire	NPS Pharmaceuticals Enrolls First Patient in Global Registry Designed to Characterize the Natural History of Hypoparathyroidism	NASDAQ:NPSP	(MM)
07/25/2013	8:10AM	Business Wire	NPS Pharmaceuticals to Report Second Quarter 2013 Financial Results	NASDAQ:NPSP	(MM)
07/25/2013	8:10AM	Business Wire	NPS Pharmaceuticals to Report Second Quarter 2013 Financial Results	NASDAQ:NPSP	(MM)
07/16/2013	4:45PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NPSP	(MM)
06/21/2013	4:10PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NPSP	(MM)
06/18/2013	4:42PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NPSP	(MM)
06/17/2013	8:00AM	Business Wire	Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Pati...	NASDAQ:NPSP	(MM)
06/17/2013	8:00AM	Business Wire	Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Pati...	NASDAQ:NPSP	(MM)
06/17/2013	8:00AM	Business Wire	Initial Findings from PARADOX, Largest & Most Comprehensive Research Analyzing the Burden of Hypoparathyroidism, Reveals Coll...	NASDAQ:NPSP	(MM)
06/17/2013	8:00AM	Business Wire	Initial Findings from PARADOX, Largest & Most Comprehensive Research Analyzing the Burden of Hypoparathyroidism, Reveals Coll...	NASDAQ:NPSP	(MM)
06/14/2013	1:20PM	Business Wire	NPS Pharmaceuticals’ President & CEO Dr. Francois Nader Receives Ernst & Young Entrepreneur Of The Year® 2013 Award in New...	NASDAQ:NPSP	(MM)
06/14/2013	1:20PM	Business Wire	NPS Pharmaceuticals’ President & CEO Dr. Francois Nader Receives Ernst & Young Entrepreneur Of The Year® 2013 Award in New...	NASDAQ:NPSP	(MM)
06/05/2013	8:11AM	Business Wire	NPS Pharmaceuticals to Present Data from Natpara™ REPLACE Study & PARADOX Study at ENDO 2013, The Endocrine Society’s 95t...	NASDAQ:NPSP	(MM)
06/05/2013	8:11AM	Business Wire	NPS Pharmaceuticals to Present Data from Natpara™ REPLACE Study & PARADOX Study at ENDO 2013, The Endocrine Society’s 95t...	NASDAQ:NPSP	(MM)
05/31/2013	9:00AM	Business Wire	NPS Pharmaceuticals Joins the Hypoparathyroidism Association in Recognition of World Hypoparathyroidism Awareness Day	NASDAQ:NPSP	(MM)
05/31/2013	9:00AM	Business Wire	NPS Pharmaceuticals Joins the Hypoparathyroidism Association in Recognition of World Hypoparathyroidism Awareness Day	NASDAQ:NPSP	(MM)
05/30/2013	6:19PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:NPSP	(MM)
05/29/2013	4:10PM	Business Wire	NPS Pharmaceuticals to Present at Jefferies Global Healthcare Conference	NASDAQ:NPSP	(MM)
05/28/2013	4:15PM	Business Wire	NPS Pharmaceuticals Announces Exercise of Over-Allotment Option and Closing of Public Offering	NASDAQ:NPSP	(MM)
05/22/2013	5:14PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:NPSP	(MM)
05/22/2013	4:37PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NPSP	(MM)
05/22/2013	4:10PM	Business Wire	NPS Pharmaceuticals to Present at Deutsche Bank Health Care Conference	NASDAQ:NPSP	(MM)
05/22/2013	6:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NPSP	(MM)
05/21/2013	5:57PM	Business Wire	NPS Pharmaceuticals Prices Public Offering of Common Stock	NASDAQ:NPSP	(MM)
05/20/2013	5:12PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:NPSP	(MM)
05/20/2013	4:21PM	Business Wire	NPS Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Shares of its Common Stock	NASDAQ:NPSP	(MM)
05/16/2013	8:00AM	Business Wire	NPS Pharmaceuticals President & CEO Dr. Francois Nader Recognized as Regional Finalist for Ernst & Young Entrepreneur of the ...	NASDAQ:NPSP	(MM)
05/15/2013	8:15AM	Business Wire	NPS Pharmaceuticals Recognized by National Organization for Rare Disorders for Gattex® as an Innovative Treatment for Patien...	NASDAQ:NPSP	(MM)
05/14/2013	5:23AM	Zacks	NPS Pharma Incurs Narrower 1Q Loss - Analyst Blog	NASDAQ:NPSP	(MM)
05/13/2013	4:24PM	Edgar (US Regulatory)	Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)	NASDAQ:NPSP	(MM)